Modulating atherosclerosis through inhibition or blockade of angiotensin. - Wikidata - wikimedia - TriplyDB

Modulating atherosclerosis through inhibition or blockade of angiotensin.

Modulating atherosclerosis through inhibition or blockade of angiotensin.

http://www.wikidata.org/entity/Q35178446

about

Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α Taurine and atherosclerosis.ANG II-induced cardiac molecular and cellular events: role of aldosterone.

P2860

Q34977437-4B1F94F2-C356-4E65-8FCE-3762734C6A32 Q38066066-D5CA2473-4860-4B10-862C-B955A918727D Q46952839-C7A6B30E-FAC3-443E-8620-3002234DA6D2

P2860

Modulating atherosclerosis through inhibition or blockade of angiotensin.

http://www.wikidata.org/entity/Q35178446

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Modulating atherosclerosis through inhibition or blockade of angiotensin.

@ast

Modulating atherosclerosis through inhibition or blockade of angiotensin.

@en

type

label

Modulating atherosclerosis through inhibition or blockade of angiotensin.

@ast

Modulating atherosclerosis through inhibition or blockade of angiotensin.

@en

prefLabel

Modulating atherosclerosis through inhibition or blockade of angiotensin.

@ast

Modulating atherosclerosis through inhibition or blockade of angiotensin.

@en

P1433

Q35178446-1959AB11-7254-4D55-A739-3D1247D35CA9

P1476

Q35178446-70267D6C-6F93-4A62-BDF3-B40B548BB09F

P2093

Q35178446-1CD046CE-E0A0-4AB0-A695-5553047C95EF

P2860

Q35178446-281DA6E9-66E6-4087-B18B-5C8D9DFA1CB7

Q35178446-397AD22C-82B2-4CFB-865D-81BCB0A2B157

Q35178446-4272063B-ED76-4866-A38D-3E2781B219A7

Q35178446-447C6666-0422-492B-8F7C-8AEB362A29AB

Q35178446-52E10359-7993-4BC0-829B-0E5B313379C1

Q35178446-5CBA30E7-4A83-415A-80A4-3D914A71AFF0

Q35178446-605B53B6-53D0-46DD-828D-ADDE2A47D622

Q35178446-AD8DF390-00D2-42C1-9754-17EEBE81DEF4

Q35178446-ADA8FC81-DFA8-45CD-B8FF-8A5A1414D6CB

Q35178446-D5913640-9977-467B-8B1A-E4ED33AA801D

P304

Q35178446-EE94C6EC-49F5-4B3C-9DD6-4596A0D1F74E

P31

Q35178446-DB4E2516-71D0-4347-A044-1F327EF66569

P356

Q35178446-B20BAF66-EF62-49F2-8282-0F5B97DD986D

P433

Q35178446-51621F01-AE1F-4B93-8F56-70778C19DDFD

P478

Q35178446-970E5DA8-A765-486C-ACEB-1DC75FADC519

P577

Q35178446-5F70829E-DCB1-4F8E-8447-3CC1FF365729

P5875

Q35178446-E37E7735-A566-4955-AA47-3CCD6C1F2D57

P698

Q35178446-4A594454-87D0-42F2-95F4-9F33CF4BCCB2

P921

Q35178446-42929831-F6F6-4904-9749-8AA4F9B552C4

P932

Q35178446-C78884D2-20DD-4F00-8484-442DBDCC0B10

P356

P1433

Clinical Cardiology

P1476

Modulating atherosclerosis through inhibition or blockade of angiotensin.

@en

P2093

Robert S Rosenson

http://www.w3.org/2001/XMLSchema#string

P2860

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

NAD(P)H oxidase: role in cardiovascular biology and disease

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

Oxidative stress as a regulator of gene expression in the vasculature.

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective.

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.

P304

305-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.4950260703

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227973799

http://www.w3.org/2001/XMLSchema#string

P698

12862295

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

6654059

http://www.w3.org/2001/XMLSchema#string